Selected research
Industry Growth & Trends
Global Oral Vaccine Delivery Industry Growth and Trends Forecast to 2032
Market perspective
The global Oral Vaccine Delivery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Oral Vaccine Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Oral Vaccine Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oral Vaccine Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oral Vaccine Delivery include Lanzhou Institute, Sanofi, Merck, Shanghai United Cell, GSK, Valneva, Vabiotech, Tiantan Biological and Serum Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Oral Vaccine Delivery market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Oral Vaccine Delivery market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Vaccine Delivery market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Vaccine Delivery.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Oral Vaccine Delivery market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Oral Vaccine Delivery Market by Company
Lanzhou Institute
Sanofi
Merck
Shanghai United Cell
GSK
Valneva
Vabiotech
Tiantan Biological
Serum Institute
PaxVax
Panacea Biotec Ltd
Halfkin Bio-Pharmaceuticals
EuBiologics
Bio-Med
Bibcol
Oral Vaccine Delivery Segment by Type
Rotavirus Vaccine
Oral Polio Vaccine
Cholera Vaccine
Other
Oral Vaccine Delivery Segment by Application
Public
Private
Oral Vaccine Delivery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccine Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccine Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccine Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Vaccine Delivery manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oral Vaccine Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rotavirus Vaccine
- Oral Polio Vaccine
- Cholera Vaccine
- Other
Applications
- Public
- Private
Companies covered
- Lanzhou Institute
- Sanofi
- Merck
- Shanghai United Cell
- GSK
- Valneva
- Vabiotech
- Tiantan Biological
- Serum Institute
- PaxVax
- Panacea Biotec Ltd
- Halfkin Bio-Pharmaceuticals
- EuBiologics
- Bio-Med
- Bibcol
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Oral Vaccine Delivery Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Oral Vaccine Delivery Sales Estimates and Forecasts (2021-2032)
- 1.3 Oral Vaccine Delivery Market by Type
- 1.3.1 Rotavirus Vaccine
- 1.3.2 Oral Polio Vaccine
- 1.3.3 Cholera Vaccine
- 1.3.4 Other
- 1.4 Global Oral Vaccine Delivery Market Size by Type
- 1.4.1 Global Oral Vaccine Delivery Market Size Overview by Type (2021-2032)
- 1.4.2 Global Oral Vaccine Delivery Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Oral Vaccine Delivery Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Oral Vaccine Delivery Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Oral Vaccine Delivery Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Oral Vaccine Delivery Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Oral Vaccine Delivery Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Oral Vaccine Delivery Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Oral Vaccine Delivery Industry Trends
- 2.2 Oral Vaccine Delivery Industry Drivers
- 2.3 Oral Vaccine Delivery Industry Opportunities and Challenges
- 2.4 Oral Vaccine Delivery Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Oral Vaccine Delivery Revenue (2021-2026)
- 3.2 Global Top Players by Oral Vaccine Delivery Sales (2021-2026)
- 3.3 Global Top Players by Oral Vaccine Delivery Price (2021-2026)
- 3.4 Global Oral Vaccine Delivery Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oral Vaccine Delivery Major Company Production Sites & Headquarters
- 3.6 Global Oral Vaccine Delivery Company, Product Type & Application
- 3.7 Global Oral Vaccine Delivery Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Oral Vaccine Delivery Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Oral Vaccine Delivery Players Market Share by Revenue in 2025
- 3.8.3 2025 Oral Vaccine Delivery Tier 1, Tier 2, and Tier 3
4 Oral Vaccine Delivery Regional Status and Outlook
- 4.1 Global Oral Vaccine Delivery Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Oral Vaccine Delivery Historic Market Size by Region
- 4.2.1 Global Oral Vaccine Delivery Sales in Volume by Region (2021-2026)
- 4.2.2 Global Oral Vaccine Delivery Sales in Value by Region (2021-2026)
- 4.2.3 Global Oral Vaccine Delivery Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Oral Vaccine Delivery Forecasted Market Size by Region
- 4.3.1 Global Oral Vaccine Delivery Sales in Volume by Region (2027-2032)
- 4.3.2 Global Oral Vaccine Delivery Sales in Value by Region (2027-2032)
- 4.3.3 Global Oral Vaccine Delivery Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Vaccine Delivery by Application
- 5.1 Oral Vaccine Delivery Market by Application
- 5.1.1 Public
- 5.1.2 Private
- 5.2 Global Oral Vaccine Delivery Market Size by Application
- 5.2.1 Global Oral Vaccine Delivery Market Size Overview by Application (2021-2032)
- 5.2.2 Global Oral Vaccine Delivery Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Oral Vaccine Delivery Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Oral Vaccine Delivery Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Oral Vaccine Delivery Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Oral Vaccine Delivery Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Oral Vaccine Delivery Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Oral Vaccine Delivery Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Lanzhou Institute
- 6.1.1 Lanzhou Institute Company Information
- 6.1.2 Lanzhou Institute Business Overview
- 6.1.3 Lanzhou Institute Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Lanzhou Institute Oral Vaccine Delivery Product Portfolio
- 6.1.5 Lanzhou Institute Recent Developments
- 6.2 Sanofi
- 6.2.1 Sanofi Company Information
- 6.2.2 Sanofi Business Overview
- 6.2.3 Sanofi Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sanofi Oral Vaccine Delivery Product Portfolio
- 6.2.5 Sanofi Recent Developments
- 6.3 Merck
- 6.3.1 Merck Company Information
- 6.3.2 Merck Business Overview
- 6.3.3 Merck Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck Oral Vaccine Delivery Product Portfolio
- 6.3.5 Merck Recent Developments
- 6.4 Shanghai United Cell
- 6.4.1 Shanghai United Cell Company Information
- 6.4.2 Shanghai United Cell Business Overview
- 6.4.3 Shanghai United Cell Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Shanghai United Cell Oral Vaccine Delivery Product Portfolio
- 6.4.5 Shanghai United Cell Recent Developments
- 6.5 GSK
- 6.5.1 GSK Company Information
- 6.5.2 GSK Business Overview
- 6.5.3 GSK Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 GSK Oral Vaccine Delivery Product Portfolio
- 6.5.5 GSK Recent Developments
- 6.6 Valneva
- 6.6.1 Valneva Company Information
- 6.6.2 Valneva Business Overview
- 6.6.3 Valneva Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Valneva Oral Vaccine Delivery Product Portfolio
- 6.6.5 Valneva Recent Developments
- 6.7 Vabiotech
- 6.7.1 Vabiotech Company Information
- 6.7.2 Vabiotech Business Overview
- 6.7.3 Vabiotech Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Vabiotech Oral Vaccine Delivery Product Portfolio
- 6.7.5 Vabiotech Recent Developments
- 6.8 Tiantan Biological
- 6.8.1 Tiantan Biological Company Information
- 6.8.2 Tiantan Biological Business Overview
- 6.8.3 Tiantan Biological Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Tiantan Biological Oral Vaccine Delivery Product Portfolio
- 6.8.5 Tiantan Biological Recent Developments
- 6.9 Serum Institute
- 6.9.1 Serum Institute Company Information
- 6.9.2 Serum Institute Business Overview
- 6.9.3 Serum Institute Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Serum Institute Oral Vaccine Delivery Product Portfolio
- 6.9.5 Serum Institute Recent Developments
- 6.10 PaxVax
- 6.10.1 PaxVax Company Information
- 6.10.2 PaxVax Business Overview
- 6.10.3 PaxVax Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 PaxVax Oral Vaccine Delivery Product Portfolio
- 6.10.5 PaxVax Recent Developments
- 6.11 Panacea Biotec Ltd
- 6.11.1 Panacea Biotec Ltd Company Information
- 6.11.2 Panacea Biotec Ltd Business Overview
- 6.11.3 Panacea Biotec Ltd Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Panacea Biotec Ltd Oral Vaccine Delivery Product Portfolio
- 6.11.5 Panacea Biotec Ltd Recent Developments
- 6.12 Halfkin Bio-Pharmaceuticals
- 6.12.1 Halfkin Bio-Pharmaceuticals Company Information
- 6.12.2 Halfkin Bio-Pharmaceuticals Business Overview
- 6.12.3 Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Product Portfolio
- 6.12.5 Halfkin Bio-Pharmaceuticals Recent Developments
- 6.13 EuBiologics
- 6.13.1 EuBiologics Company Information
- 6.13.2 EuBiologics Business Overview
- 6.13.3 EuBiologics Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 EuBiologics Oral Vaccine Delivery Product Portfolio
- 6.13.5 EuBiologics Recent Developments
- 6.14 Bio-Med
- 6.14.1 Bio-Med Company Information
- 6.14.2 Bio-Med Business Overview
- 6.14.3 Bio-Med Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Bio-Med Oral Vaccine Delivery Product Portfolio
- 6.14.5 Bio-Med Recent Developments
- 6.15 Bibcol
- 6.15.1 Bibcol Company Information
- 6.15.2 Bibcol Business Overview
- 6.15.3 Bibcol Oral Vaccine Delivery Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Bibcol Oral Vaccine Delivery Product Portfolio
- 6.15.5 Bibcol Recent Developments
7 North America by Country
- 7.1 North America Oral Vaccine Delivery Sales by Country
- 7.1.1 North America Oral Vaccine Delivery Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Oral Vaccine Delivery Sales by Country (2021-2026)
- 7.1.3 North America Oral Vaccine Delivery Sales Forecast by Country (2027-2032)
- 7.2 North America Oral Vaccine Delivery Market Size by Country
- 7.2.1 North America Oral Vaccine Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Oral Vaccine Delivery Market Size by Country (2021-2026)
- 7.2.3 North America Oral Vaccine Delivery Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Oral Vaccine Delivery Sales by Country
- 8.1.1 Europe Oral Vaccine Delivery Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Oral Vaccine Delivery Sales by Country (2021-2026)
- 8.1.3 Europe Oral Vaccine Delivery Sales Forecast by Country (2027-2032)
- 8.2 Europe Oral Vaccine Delivery Market Size by Country
- 8.2.1 Europe Oral Vaccine Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Oral Vaccine Delivery Market Size by Country (2021-2026)
- 8.2.3 Europe Oral Vaccine Delivery Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Oral Vaccine Delivery Sales by Country
- 9.1.1 Asia-Pacific Oral Vaccine Delivery Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Oral Vaccine Delivery Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Oral Vaccine Delivery Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Oral Vaccine Delivery Market Size by Country
- 9.2.1 Asia-Pacific Oral Vaccine Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Oral Vaccine Delivery Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Oral Vaccine Delivery Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Oral Vaccine Delivery Sales by Country
- 10.1.1 South America Oral Vaccine Delivery Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Oral Vaccine Delivery Sales by Country (2021-2026)
- 10.1.3 South America Oral Vaccine Delivery Sales Forecast by Country (2027-2032)
- 10.2 South America Oral Vaccine Delivery Market Size by Country
- 10.2.1 South America Oral Vaccine Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Oral Vaccine Delivery Market Size by Country (2021-2026)
- 10.2.3 South America Oral Vaccine Delivery Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Oral Vaccine Delivery Sales by Country
- 11.1.1 Middle East and Africa Oral Vaccine Delivery Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Oral Vaccine Delivery Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Oral Vaccine Delivery Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Oral Vaccine Delivery Market Size by Country
- 11.2.1 Middle East and Africa Oral Vaccine Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Oral Vaccine Delivery Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Oral Vaccine Delivery Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Oral Vaccine Delivery Value Chain Analysis
- 12.1.1 Oral Vaccine Delivery Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Oral Vaccine Delivery Production Mode & Process
- 12.2 Oral Vaccine Delivery Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Oral Vaccine Delivery Distributors
- 12.2.3 Oral Vaccine Delivery Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst